Seoul National University Bundang Hospital (SNUBH)
Liver cancer stage 4 treatment cost in South Korea typically depends on the complex mix of palliative care and advanced therapies required. A primary diagnostic like an abdominal CT scan costs AUD $833 – AUD $1,249, while specialized chemotherapy runs from AUD $26,643 to AUD $56,895. Total expenses vary by hospital tier and drug protocols, but patients often save between 40–60% compared to private healthcare in Australia or the United States. Most international treatment centres are located in Seoul.
Typical Liver Cancer Stage 4 Treatment Costs in South Korea
Bookimed Expert Insight: For advanced cases, multidisciplinary care is vital. Asan Medical Center reports a 90% organ transplant success rate, which is significant for eligible complex cases. Patients seeking digital safety protocols should consider Seoul National University Bundang Hospital. It uses the BESTcare system to reduce medical errors. If choosing a JCI-accredited facility, Severance Hospital is a popular choice for coordinated international patient care.
| Republic of Korea | Thailand | Turkey | |
| Chemotherapy for breast cancer | from AUD $26,643 | from AUD $4,163 | from AUD $1,665 |
No hidden fees – just official clinic prices. Pay at the clinic for Liver cancer stage 4 treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Liver cancer stage 4 treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Liver cancer stage 4 treatment journey.
Professor Lee Seok-gu is a leading liver transplant surgeon at Myongji Hospital. He has performed about 2,000 liver transplants. He achieved Korea’s first transfusion-free liver transplant. He performed hepatocyte transplantation in a one-month-old infant. He led the first clinical use of a bioartificial liver for acute liver failure. He also performed living-donor transplants in Egypt and trained teams in Vietnam.
He is Professor of Surgery at Myongji Hospital and former Director of the Organ Transplantation Center at Samsung Medical Center. He earned his MD and MSc from Seoul National University and his PhD from the Catholic University of Korea. He completed a fellowship at Boston Children’s Hospital/Harvard and transplant training at Johns Hopkins. He served as president of three national societies in transplantation and pediatric surgery. His honors include the Chong Kun Dang Award, the Pfizer Clinical Medicine Award, and the Astellas Investigator Award. He has 447 publications and 13 book chapters.
South Korean hospitals offer advanced stage 4 liver cancer treatments. These include immunotherapy combinations, proton beam therapy, and radioembolisation (TARE). Major JCI-accredited centres in Seoul use multidisciplinary teams. These teams combine systemic drugs with precise liver-targeted therapies. These approaches aim to control tumour growth and maintain quality of life.
Bookimed Expert Insight: South Korea leads in 'downstaging' strategies. These strategies use intensive immunotherapy to shrink advanced tumours enough for surgery. Data from Seoul National University Hospital shows their cancer survival rates often exceed global averages. This success stems from high patient volumes. Major centres like SNUBH see 1,500,000 patients annually.
Patient Consensus: Patients in the Republic of Korea emphasise getting second opinions across university-affiliated centres. They often find immunotherapy-based treatments and liver-directed therapies like TACE provide the best results. This is especially true for advanced disease.
Stage 4 liver cancer patients in South Korea may access surgery or transplantation through protocols. Surgery is usually restricted to early stages. Centres like Asan Medical Center often expand the criteria for living donor liver transplantation. They do this only if tumours respond well to initial therapy. The tumours must not have spread beyond the liver.
Bookimed Expert Insight: Stage 4 often rules out surgery. However, South Korea specialises in living donor liver transplantation (LDLT). Data shows major centres like Seoul National University Hospital have completed 1,000+ liver transplants. Their surgeons often accept complex cases that fall outside standard international criteria. They do this if local treatment first stabilises the disease.
Patient Consensus: Patients emphasise the need for a second opinion at major South Korean university hospitals. They note that bringing detailed pathology and staging records is essential. This helps determine if any surgical exception pathway exists.
South Korean hospitals offer TACE for stage 4 liver cancer to control tumour growth and manage symptoms. Specialist centres use superselective TACE to target specific blood vessels. This technique delivers intensive chemotherapy directly to tumours. It spares healthy liver tissue to improve survival rates.
Bookimed Expert Insight: South Korea is a global hub for liver care, with Asan Medical Center performing over 65,000 surgeries annually. Their 98% liver transplant success rate suggests strong hepatology expertise. This benefits TACE patients. For stage 4 cases, these high-volume centres often provide same-day consultations. They also offer rapid admission to expedite treatment.
Patient Consensus: Patients note that stage 4 does not automatically rule out TACE in South Korea. They frequently highlight the successful use of mapping procedures and overnight stays. These make sure the catheter-based chemotherapy is tolerated well.
South Korea runs clinical trials for stage 4 liver cancer. Patients can access novel therapies such as patient-derived Natural Killer cells and Cytokine-Induced Killer treatments. Major Seoul centres supply personalised strategies assisted by AI, plus proton therapy for advanced cases. Research focuses heavily on second-line immunotherapy combinations.
Bookimed Expert Insight: South Korea is a global oncology hub, ranking 6th for medical travel requests. Institutions like Asan Medical Center report a 98% liver transplant success rate. This level of surgical expertise often correlates with more robust clinical trial infrastructure. Patients should look for hospitals with high transplant volumes for the most advanced stage 4 options.
Patient Consensus: Patients note Korean research is active in innovation for advanced cancer. They emphasise getting a second opinion at major Seoul centres to discuss trial eligibility based on tumour markers.
South Korea reports a 5-year survival rate of approximately 6% for stage 4 liver cancer. Major Seoul hospitals use a multimodal system. This combines immunotherapy, TACE and proton beam therapy. These centres manage complex cases with vascular invasion that are often considered inoperable elsewhere.
Bookimed Expert Insight: While stage 4 is often incurable, South Korea's high volume of transplants creates a unique safety net. Asan Medical Center performs more organ transplants than any other Korean facility. This massive caseload means specialists are exceptionally skilled. They manage liver function during intensive systemic treatments. This experience often allows patients to continue therapy longer than in lower-volume centres.
Patient Consensus: Patients find that stage 4 treatment primarily focuses on symptom control and life extension. However, Korean centres offer hope through liver-directed procedures. The high quality of care and efficient diagnostic timelines in Seoul provide reassurance. This is especially valuable during complex treatment.
South Korea houses world-leading liver cancer centres specialising in advanced stage 4 cases. Top hospitals include Asan Medical Centre and Severance Hospital. Asan Medical Centre has a 98% liver transplant success rate. Severance Hospital is JCI-accredited. These institutions provide multidisciplinary teams and technologies like TARE and robotic surgery.
Bookimed Expert Insight: Many search for the newest technology. However, the raw volume of cases defines Korean excellence. Asan Medical Centre alone performs over 65,000 operations yearly. With this throughput, surgeons often manage more stage 4 cases in a month. That is more than many Western specialists see in a year. High volume leads to more refined surgical techniques and fewer post-operative complications.
Patient Consensus: Patients note that major Seoul hospitals often require repeat diagnostic scans upon arrival. This can delay treatment. They recommend choosing clinics with dedicated international coordinators. These coordinators help navigate administrative hurdles in South Korea.